Sort by 'shares'
Multiple Myeloma Stem Cells and Drug Resistance in Myeloma Management
Multiple myeloma is a heterogenous plasma cell disorder that contains a small fraction of clonogenic stem cells, just like many other cancers. Although the exact nature and biological properties of these cells remain elusive, multiple myeloma stem cells (MMSCs) have…
Novel Technologies to Check Male Fertility Status with Dr. Jamin Brahmbhatt
Male factor infertility accounts for 50% of total cases of troubled conception. Unfortunatley male infertility is not as promptly reported as female infertility which is tracked by Society for Assisted Reproductive Technology database. One key reason for under-reporting of male…
The Promise of Prevention. Multiple Myeloma and The Promise Study
Nearly all patients with multiple myeloma first develop one of its precursor conditions. People with these conditions do not have any symptoms, and they are told to watch and wait to see if they develop multiple myeloma. Currently, there are…
Evolving Treatment Landscape of Psoriasis. More than Skin Deep.
Psoriasis is one of the most common skin ailments, affecting about 2 percent of the population, across gender, age or socioeconomic status. The impact of this autoimmune skin condition goes much deeper with raised cardiovascular risk, inflammatory arthritis and other…
Myeloma 2015. Year in Review with the MMRF
2015 saw a lot of action in the Myeloma world. Four new drugs were approved by the FDA increasing treatment options and allowing new combination regimens; promising immunotherapy research results will see these being used in clinical practice and 1000…